Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Dosing Schedule in HCC
NCT01203787Phase 4Completed
- Sponsor
- University of Florida
- Start
- Dec 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by University of Florida. Started Dec 2010; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01203787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203787.